Financials
- Market Capitalization 8.46 B
- Employee 131
- Founded 2006
- CEO N/A
- Website www.protagonist-inc.com
- Headquarter Delaware, United States
- FIGI BBG002B63KM7
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-58.23
Rapporto prezzo/fatturato
97.79
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 988 | CRNX Crinetics Pharmaceuticals, Inc. - Common Stock | 83.86 USD | +0.18% | +0.41% | +137.83% | +104.04% | 8.84 B USD | ||
| 999 | SYRE Spyre Therapeutics, Inc. - Common Stock | 98.12 USD | -0.84% | +3.96% | +17.45% | +310.37% | 8.52 B USD | ||
| 1010 | TGTX TG Therapeutics, Inc. - Common Stock | 53.99 USD | -1.64% | -6.79% | +7.68% | +41.00% | 8.26 B USD | ||
| 1017 | APGE Apogee Therapeutics, Inc. - Common Stock | 133.99 USD | +0.02% | +0.25% | +55.46% | +150.03% | 8.29 B USD |